E. Özkaya Et Al. , "Long-term dupilumab therapy in Netherton syndrome with severe atopic manifestations: Case report and review of the literature," Australasian Journal of Dermatology , vol.64, no.2, pp.272-277, 2023
Özkaya, E. Et Al. 2023. Long-term dupilumab therapy in Netherton syndrome with severe atopic manifestations: Case report and review of the literature. Australasian Journal of Dermatology , vol.64, no.2 , 272-277.
Özkaya, E., Günay, M. B., Babuna Kobaner, G., Keskinkaya, Z., & Gökalp, M. O., (2023). Long-term dupilumab therapy in Netherton syndrome with severe atopic manifestations: Case report and review of the literature. Australasian Journal of Dermatology , vol.64, no.2, 272-277.
Özkaya, Esen Et Al. "Long-term dupilumab therapy in Netherton syndrome with severe atopic manifestations: Case report and review of the literature," Australasian Journal of Dermatology , vol.64, no.2, 272-277, 2023
Özkaya, Esen Et Al. "Long-term dupilumab therapy in Netherton syndrome with severe atopic manifestations: Case report and review of the literature." Australasian Journal of Dermatology , vol.64, no.2, pp.272-277, 2023
Özkaya, E. Et Al. (2023) . "Long-term dupilumab therapy in Netherton syndrome with severe atopic manifestations: Case report and review of the literature." Australasian Journal of Dermatology , vol.64, no.2, pp.272-277.
@article{article, author={Esen Özkaya Et Al. }, title={Long-term dupilumab therapy in Netherton syndrome with severe atopic manifestations: Case report and review of the literature}, journal={Australasian Journal of Dermatology}, year=2023, pages={272-277} }